Pierre Gravier
Independent DirectorMr. Pierre Gravier, MS, is Independent Director of Filana Therapeutics, Inc. (formerly known as Cassava Sciences, Inc.) from 2024 and served as its Director from December 8, 2023 until 2024. He serves as Chief Financial Officer at PTC Therapeutics, Inc. since July 13, 2023. He is an experienced healthcare finance strategist. He has experience as an investment banker, venture capitalist and scientist to PTC. He served as Managing Director of Advisory at Perella Weinberg Partners LP From 2013 to July 2023. Mr. Gravier served as an Executive Director of Advisory at Perella Weinberg Partners LP. Mr. Gravier served as Director of Advisory at Perella Weinberg Partners LP. At Perella Weinberg, he focused on advising companies in the biopharmaceutical and pharmaceutical sectors on finance strategy and corporate development. Mr. Gravier was an Associate at Barclays Capital, where he advised clients in the pharmaceutical, specialty pharmaceutical and medical device industries on mergers and acquisitions and capital raising transactions. He worked as a healthcare investment banker at Barclays Capital in London. Previously, he was a Venture Capital Analyst at Société Générale Asset Management, where he focused on early stage investments in the biotechnology sector. Prior to that, Mr. Gravier began his career as a Scientist at Ferring Pharmaceuticals from 2006 to 2007. Mr. Gravier received a Master’s Degree in Finance from ESCP Business School and a Master of Science in Bioengineering from the University of Technology of Compiègne.
Positions
- Company NameFilana Therapeutics, Inc.Stock CodeFLNAPositionIndependent DirectorColleagues
- RJRichard Jon BarryCEO, President & Director
- CNClaude NicaiseIndependent Chairman
- EJEric J. SchoenChief Financial Officer
- RCR. Christopher CookChief Operating & Legal Officer
- GTGeorge ThorntonSenior Vice President of Technology
- MZMichael ZamlootSenior Vice President of Technical Operations
- PGPierre GravierIndependent Director
- RERobert Eugene AndersonIndependent Director
- GLGrant L. SchoenhardMember of Scientific Advisory Board
- Company NamePTC Therapeutics, Inc.Stock CodePTCTPositionChief Financial OfficerColleagues
- MBMatthew B. KleinCEO & Director
- MSMichael SchmertzlerIndependent Chairman of the Board
- ASAllan Steven JacobsonCo-Founder & Independent Director
- NANeil AlmsteadChief Technical Operations Officer
- EPEric PauwelsChief Business Officer
- GDGlenn Daniel SteeleIndependent Director
- EREmma ReeveIndependent Director
